Head to Head Comparison: C.P. Pokphand (OTCMKTS:CPKPY) versus MDxHealth (OTCMKTS:MXDHF)

MDxHealth (OTCMKTS:MXDHF) and C.P. Pokphand (OTCMKTS:CPKPY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.

Profitability

This table compares MDxHealth and C.P. Pokphand’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
MDxHealth	N/A	N/A	N/A
C.P. Pokphand	N/A	N/A	N/A

Earnings & Valuation

This table compares MDxHealth and C.P. Pokphand”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MDxHealth	$37.05 million	0.00	-$44.04 million	N/A	N/A
C.P. Pokphand	$4.33 billion	0.82	$2.16 billion	N/A	N/A

C.P. Pokphand has higher revenue and earnings than MDxHealth.

Volatility and Risk

MDxHealth has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Comparatively, C.P. Pokphand has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500.

Insider & Institutional Ownership

0.0% of C.P. Pokphand shares are owned by institutional investors. 1.7% of MDxHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings for MDxHealth and C.P. Pokphand, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MDxHealth	0	0	1	0	3.00
C.P. Pokphand	0	0	0	0	0.00

Given MDxHealth’s stronger consensus rating and higher probable upside, equities analysts clearly believe MDxHealth is more favorable than C.P. Pokphand.

Summary

MDxHealth beats C.P. Pokphand on 5 of the 8 factors compared between the two stocks.

About MDxHealth

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

About C.P. Pokphand

CP Pokphand Co. Ltd. is an investment holding company, which engages in the manufacture and trade of animal feed products. It operates through the following business segments: China Agri-Food; Vietnam Agri-Food; and Investment and Property Holding. The China Agri-Food segment produces and distributes animal feed and processed food. The Vietnam Agri-Food segment breeds, farms, and sells livestock and aquatic animals. The Investment and Property Holding segment manages and leases out residential and commercial projects. The company was founded in 1987 and is headquartered in Hong Kong.